| Pharyngeal Neoplasm studied in …STUDIED_INderived200 of 1,344show all (up to 200) |
|---|
| → studied in | NCT04085900recruiting Screening Nasopharyngeal Carcinoma With EBV Associated Biomarkers in Zhongshan City · condition mapped ONTOLOGY_EXACT · 1,344 trials mapped (507 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06309225NA · recruiting Dose Adjusted Chemoradiotherapy in HPV-Associated Oropharynx Cancer of the Elderly · condition mapped ALIAS · 1,344 trials mapped (507 active) | — | — | Malignant Oropharyngeal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06479811Phase 1 · recruiting [212Pb]VMT-Alpha-NET in Metastatic or Inoperable Somatostatin-Receptor Positive Gastrointestinal Neuroendocrine Tumors, Pheochromocytoma/Paragangliomas, Small Cell Lung, Renal Cell, and Head and Neck Cancers · condition mapped ONTOLOGY_EXACT · 1,344 trials mapped (507 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06589804Phase 3 · recruiting Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment · condition mapped CURATED_BROADER · 1,344 trials mapped (507 active) | — | — | Hypopharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07667400Phase 1/Phase 2 · not yet recruiting Docetaxel and SX-682 in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma, Salivary Gland Carcinoma, and Advanced Prostate Cancer · condition mapped ONTOLOGY_EXACT · 1,344 trials mapped (507 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03429036recruiting Biospecimen Procurement for Head and Neck Disorders · condition mapped ONTOLOGY_EXACT · 1,344 trials mapped (507 active) | — | — | Pharyngeal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03644563active not recruiting Men and Women Offering Understanding of Throat HPV · condition mapped CURATED_EXACT · 1,344 trials mapped (507 active) | — | — | Malignant Oropharyngeal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05136196Phase 2 · recruiting BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study · condition mapped CURATED_BROADER · 1,344 trials mapped (507 active) | — | — | Hypopharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06980038Phase 2 · recruiting Testing Whether Cemiplimab (REGN2810) Plus CDX-1140 Given Prior to Surgery Are Better Than Cemiplimab (REGN2810) Alone in Patients With Stage III-IV Head and Neck Cancer · condition mapped ONTOLOGY_EXACT · 1,344 trials mapped (507 active) | — | — | Hypopharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05290194Phase 2 · withdrawn Radiotherapy Combined With PD-1 Monoclonal Antibody and Capecitabine in the Treatment of Nasopharyngeal Carcinoma · condition mapped ONTOLOGY_EXACT · 1,344 trials mapped (507 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05814549active not recruiting A Study Using Human Papillomavirus (HPV) DNA Testing to Detect HPV-Related Oropharyngeal Cancer (OPC) · condition mapped CURATED_EXACT · 1,344 trials mapped (507 active) | — | — | Malignant Oropharyngeal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06305676recruiting Biomarker Approach to Screening for the Early Detection of HPV-related Oropharyngeal Cancer (BASH OPC) · condition mapped CURATED_EXACT · 1,344 trials mapped (507 active) | — | — | Malignant Oropharyngeal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04266093enrolling by invitation Gene Therapy Follow up Protocol for Subjects Previously Enrolled in NCI Center for Immuno-Oncology Studies · condition mapped ONTOLOGY_EXACT · 1,344 trials mapped (507 active) | — | — | Oropharyngeal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04671667Phase 2 · recruiting Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma · condition mapped CURATED_BROADER · 1,344 trials mapped (507 active) | — | — | Hypopharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04708470Phase 1/Phase 2 · completed A Phase I/II Study of Combination Immunotherapy for Advanced Cancers Including HPV-Associated Malignancies, Small Bowel, and Colon Cancers · condition mapped CURATED_EXACT · 1,344 trials mapped (507 active) | — | — | Malignant Oropharyngeal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05172245Phase 1 · recruiting Testing the Addition of Ipatasertib to Usual Chemotherapy and Radiation for Head and Neck Cancer · condition mapped CURATED_BROADER · 1,344 trials mapped (507 active) | — | — | Hypopharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07060261NA · recruiting Pre-Op MRI on Margin Status for Transoral Robotic Surgery for HPV+ Tonsillar Squamous Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 1,344 trials mapped (507 active) | — | — | Tonsillar Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07565740Phase 1 · recruiting Intranasal WSK-IM05 Vaccine Plus Tislelizumab as Neoadjuvant Therapy for HPV+ OPSCC · condition mapped ALIAS · 1,344 trials mapped (507 active) | — | — | Human Papillomavirus-Related Oropharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05172258Phase 2 · active not recruiting Testing the Addition of an Anti-cancer Drug, Ipatasertib, to the Usual Immunotherapy Treatment (Pembrolizumab) in Patients With Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck · condition mapped CURATED_BROADER · 1,344 trials mapped (507 active) | — | — | Hypopharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05904080Phase 2 · suspended Testing Nivolumab and Ipilimumab Immunotherapy With or Without the Targeted Drug Cabozantinib in Recurrent, Metastatic, or Incurable Nasopharyngeal Cancer · condition mapped CURATED_BROADER · 1,344 trials mapped (507 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05983432Phase 1 · recruiting Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors · condition mapped CURATED_EXACT · 1,344 trials mapped (507 active) | — | — | Malignant Nasopharyngeal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07832266Phase 1 · not yet recruiting Proactively Intervening On Early Cranial Nerve Injury As A Delayed Sequela Of Oropharyngeal Cancer: A Randomized Feasibility Clinical Trial For Pro-Habilitation (proNERVE RCT) · condition mapped CURATED_EXACT · 1,344 trials mapped (507 active) | — | — | Malignant Oropharyngeal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00498875active not recruiting Depression and Adherence in Head and Neck Cancer · condition mapped CURATED_EXACT · 1,344 trials mapped (507 active) | — | — | Malignant Oropharyngeal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05798780NA · completed The ENHANCE Study: Exercise and Nutrition in Head And Neck CancEr Survivors · condition mapped ALIAS · 1,344 trials mapped (507 active) | — | — | Malignant Oropharyngeal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06629597Phase 3 · active not recruiting A Phase III Study of YL201 in Recurrent or Metastatic Nasopharyngeal Carcinoma (TAISHAN-301) · condition mapped ONTOLOGY_EXACT · 1,344 trials mapped (507 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07177443Phase 3 · recruiting Serplulimab Combined With Induction Chemotherapy and Radiotherapy in Nasopharyngeal Carcinoma · condition mapped CURATED_BROADER · 1,344 trials mapped (507 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07824856Phase 2 · not yet recruiting Local Ablation Plus Systemic Therapy for Metachronous Liver and/or Lung Oligometastases From Nasopharyngeal Carcinoma · condition mapped ONTOLOGY_EXACT · 1,344 trials mapped (507 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06029270Phase 2 · recruiting Testing the Addition of BMS-986016 (Relatlimab) to the Usual Immunotherapy After Initial Treatment for Recurrent or Metastatic Nasopharyngeal Cancer · condition mapped CURATED_BROADER · 1,344 trials mapped (507 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07797881Phase 2 · not yet recruiting A Study of BL-B01D1 With or Without PD-1 Monoclonal Antibody in Patients With High-Risk Locally Advanced Nasopharyngeal Carcinoma · condition mapped ONTOLOGY_EXACT · 1,344 trials mapped (507 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05880797recruiting Multidimensional and Multimodal Profiling of Oropharyngeal Carcinoma · condition mapped ONTOLOGY_EXACT · 1,344 trials mapped (507 active) | — | — | Oropharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07783321Phase 3 · not yet recruiting A Study of Anti-PD-1 Antibody With or Without BL-B01D1 as Maintenance Therapy Following Anti-PD-1 Antibody Plus Chemotherapy for the First-line Treatment of Recurrent or Metastatic Nasopharyngeal Carcinoma (PANKU-NPC02) · condition mapped ONTOLOGY_EXACT · 1,344 trials mapped (507 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07819656recruiting Dynamic Risk Prediction of Severe Myelosuppression in Nasopharyngeal Carcinoma · condition mapped ONTOLOGY_EXACT · 1,344 trials mapped (507 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02734537Phase 2 · recruiting Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery · condition mapped ONTOLOGY_EXACT · 1,344 trials mapped (507 active) | — | — | Hypopharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03074513Phase 2 · active not recruiting Atezolizumab and Bevacizumab in Treating Patients With Rare Solid Tumors · condition mapped CURATED_BROADER · 1,344 trials mapped (507 active) | — | — | Malignant Nasopharyngeal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04255849Phase 3 · active not recruiting Nine-valent HPV Vaccine to Prevent Persistent Oral HPV Infection in Men Living With HIV · condition mapped ALIAS · 1,344 trials mapped (507 active) | — | — | Human Papillomavirus-Related Oropharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05721755Phase 3 · active not recruiting Combining Radiation Therapy With Immunotherapy for the Treatment of Metastatic Squamous Cell Carcinoma of the Head and Neck · condition mapped CURATED_BROADER · 1,344 trials mapped (507 active) | — | — | Hypopharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05752149Phase 2 · recruiting Fluorescence-guided Surgery in Laryngeal- and Hypopharyngeal Cancer: a Feasibility Trial · condition mapped ALIAS · 1,344 trials mapped (507 active) | — | — | Hypopharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06064097Phase 2 · recruiting A Study Using Nivolumab, in Combination With Chemotherapy Drugs to Treat Nasopharyngeal Carcinoma (NPC) · condition mapped CURATED_BROADER · 1,344 trials mapped (507 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07513389Phase 2 · recruiting Omission of Postoperative Radiation in HPV-Associated Oropharyngeal Cancer Using ctHPVDNA Surveillance (OPERATION) · condition mapped ONTOLOGY_EXACT · 1,344 trials mapped (507 active) | — | — | Oropharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07818486Phase 1/Phase 2 · not yet recruiting A Study of BL-M08D1 in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma and Other Solid Tumors · condition mapped ONTOLOGY_EXACT · 1,344 trials mapped (507 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06055868active not recruiting People Living With HIV, Oral and Oropharyngeal Cancer, and Health Equity · condition mapped ONTOLOGY_EXACT · 1,344 trials mapped (507 active) | — | — | Oropharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02135042Phase 2/Phase 3 · active not recruiting Individualized Treatment in Treating Patients With Stage II-IVB Nasopharyngeal Cancer Based on EBV DNA · condition mapped CURATED_BROADER · 1,344 trials mapped (507 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07513324Phase 2 · not yet recruiting Risk-adapted Therapy in HPV-positive Oropharyngeal Cancer Using Circulating Tumor (ct) HPV DNA Profiling (ReACT 2.0) · condition mapped ALIAS · 1,344 trials mapped (507 active) | — | — | Human Papillomavirus-Related Oropharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07812467Phase 2 · not yet recruiting Rimegepant-Sensitized Neoadjuvant Chemoimmunotherapy for Oral or Oropharyngeal Squamous Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 1,344 trials mapped (507 active) | — | — | Oropharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07038343Phase 1/Phase 2 · recruiting AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001) · condition mapped CURATED_EXACT · 1,344 trials mapped (507 active) | — | — | Malignant Nasopharyngeal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07156227Phase 1 · recruiting Testing the Addition of an Anti-Cancer Drug, Camonsertib, to Radiation Therapy for Recurrent Head and Neck Squamous Cell Carcinoma · condition mapped CURATED_BROADER · 1,344 trials mapped (507 active) | — | — | Hypopharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06761937Phase 1 · active not recruiting Thermotherapy for Locally Advanced Head and Neck Cancer · condition mapped ONTOLOGY_EXACT · 1,344 trials mapped (507 active) | — | — | Oropharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06763289active not recruiting Comparison of Multi-omics Models for Early Nasopharyngeal Carcinoma Screening: cfDNA Methylation, EBV DNA, and Serological Double-antibodies Detection · condition mapped ONTOLOGY_EXACT · 1,344 trials mapped (507 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06790966Phase 3 · terminated Phase 3 Study of PDS0101 and Pembrolizumab in HPV16+ Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma · condition mapped ALIAS · 1,344 trials mapped (507 active) | — | — | Human Papillomavirus-Related Oropharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07532538recruiting A Machine Learning-Based Risk Prediction Model for Head and Neck Cancerous Lesions · condition mapped CURATED_EXACT · 1,344 trials mapped (507 active) | — | — | Malignant Hypopharyngeal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07625423Phase 1 · recruiting Intratumoral Injection of Recombinant Human Endostatin Adenovirus (EDS01) for the Treatment of Recurrent or Metastatic Head and Neck Tumors · condition mapped ALIAS · 1,344 trials mapped (507 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07690618Phase 1 · recruiting Thermotherapy for Head and Neck Cancer Patients · condition mapped ONTOLOGY_EXACT · 1,344 trials mapped (507 active) | — | — | Oropharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01810913Phase 2/Phase 3 · suspended Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck Cancer · condition mapped ONTOLOGY_EXACT · 1,344 trials mapped (507 active) | — | — | Oropharyngeal p16INK4a-Negative Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06787456recruiting "Xijiang Project" Screening Cohort for NPC · condition mapped ONTOLOGY_EXACT · 1,344 trials mapped (507 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07796789Phase 3 · recruiting Prophylactic Nanocrystalline Megestrol Acetate Versus Placebo for Chemoradiotherapy-Related Anorexia in Nasopharyngeal Carcinoma · condition mapped ALIAS · 1,344 trials mapped (507 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07797738NA · not yet recruiting Prognostic Biomarkers for Patients With Human Papillomavirus (HPV) Positive Oropharyngeal Squamous Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 1,344 trials mapped (507 active) | — | — | Oropharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05126719Phase 2 · active not recruiting A Study to Evaluate the Efficacy and Safety of MRG003 in Patients With Recurrent Metastatic Nasopharyngeal Carcinoma · condition mapped ONTOLOGY_EXACT · 1,344 trials mapped (507 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06976190Phase 3 · recruiting A Study of MRG003 in Combination With Pucotenlimab Versus Chemotherapy in the Treatment of Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma · condition mapped ONTOLOGY_EXACT · 1,344 trials mapped (507 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07768189Phase 3 · not yet recruiting A Study to Evaluate CRB-701 Compared to Investigator's Choice Therapy in Previously Treated Oropharyngeal Squamous Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 1,344 trials mapped (507 active) | — | — | Oropharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07794488Phase 2 · not yet recruiting Platinum-Free Regimen in Nasopharyngeal Carcinoma · condition mapped ALIAS · 1,344 trials mapped (507 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00588770Phase 3 · active not recruiting Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma · condition mapped CURATED_BROADER · 1,344 trials mapped (507 active) | — | — | Hypopharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07781852early Phase 1 · not yet recruiting Evaluation of the Distribution of 64Cu/68Ga Labeled CM500 in Healthy Volunteers and Patients With Cancer · condition mapped CURATED_BROADER · 1,344 trials mapped (507 active) | — | — | Malignant Pharyngeal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03258554Phase 2/Phase 3 · completed Radiation Therapy With Durvalumab or Cetuximab in Treating Patients With Locoregionally Advanced Head and Neck Cancer Who Cannot Take Cisplatin · condition mapped ONTOLOGY_EXACT · 1,344 trials mapped (507 active) | — | — | Hypopharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07058805Phase 2 · recruiting Compartmentalized Postoperative Radiotherapy in Head and Neck Cancer · condition mapped ONTOLOGY_EXACT · 1,344 trials mapped (507 active) | — | — | Oropharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07137052recruiting Precise Guidance of Adaptive Radiotherapy for Nasopharyngeal Carcinoma · condition mapped ONTOLOGY_EXACT · 1,344 trials mapped (507 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07201337Phase 3 · active not recruiting Reduced-dose vs Standard-dose Irradiation for Low-risk Clinical Target Volume in Nasopharyngeal Carcinoma. · condition mapped ALIAS · 1,344 trials mapped (507 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07789158Phase 2 · not yet recruiting Induction Chemotherapy Response-Guided Reduced-Dose Radiotherapy for Nasopharyngeal Carcinoma · condition mapped ONTOLOGY_EXACT · 1,344 trials mapped (507 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04456322Phase 3 · active not recruiting Radiotherapy Plus Nimotuzumab or Cisplatin in Nasopharyngeal Carcinoma · condition mapped ONTOLOGY_EXACT · 1,344 trials mapped (507 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06016920Phase 1/Phase 2 · recruiting Safety and Efficacy of VB10.16 and Pembrolizumab in Patients With Head-Neck Squamous Cell Carcinoma · condition mapped ALIAS · 1,344 trials mapped (507 active) | — | — | Human Papillomavirus-Related Oropharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07784855NA · not yet recruiting Scheduled IV Fluids in the Supportive Management of Patients Undergoing Chemo-radiotherapy for Head and Neck Cancer · condition mapped ALIAS · 1,344 trials mapped (507 active) | — | — | Hypopharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04178174Phase 3 · recruiting Stereotactic Boost and Short-course Radiation Therapy for Oropharynx Cancer · condition mapped ALIAS · 1,344 trials mapped (507 active) | — | — | Malignant Oropharyngeal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04901234Phase 2 · recruiting Adaptive RadioTherapy for OroPharynx Cancer · condition mapped ALIAS · 1,344 trials mapped (507 active) | — | — | Malignant Oropharyngeal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04910347Phase 2 · active not recruiting Consolidation Nivolumab After Concurrent Chemoradiotherapy in Locally Advanced Nasopharyngeal Carcinoma · condition mapped CURATED_BROADER · 1,344 trials mapped (507 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07781358Phase 2 · recruiting Becotatug Vedotin Combined With a PD-1 Inhibitor in the Treatment of Locally Advanced Recurrent Nasopharyngeal Carcinoma. · condition mapped ONTOLOGY_EXACT · 1,344 trials mapped (507 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01893307Phase 3 · active not recruiting Intensity-Modulated Proton Beam Therapy or Intensity-Modulated Photon Therapy in Treating Patients With Stage III-IVB Oropharyngeal Cancer · condition mapped CURATED_BROADER · 1,344 trials mapped (507 active) | — | — | Oropharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04576091Phase 1 · active not recruiting Testing the Addition of an Anti-cancer Drug, BAY 1895344, With Radiation Therapy to the Usual Pembrolizumab Treatment for Recurrent Head and Neck Cancer · condition mapped CURATED_BROADER · 1,344 trials mapped (507 active) | — | — | Hypopharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05245682early Phase 1 · active not recruiting Tolinapant and Radiation for Cisplatin-Ineligible, Previously Untreated, Locally Advanced Head and Neck Cancer · condition mapped CURATED_BROADER · 1,344 trials mapped (507 active) | — | — | Hypopharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06563362Phase 2 · recruiting Personalized Volume-deescalated Elective Nodal Irradiation in Oropharyngeal Head and Neck Squamous Cell Carcinoma · condition mapped ALIAS · 1,344 trials mapped (507 active) | — | — | Malignant Oropharyngeal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06223568Phase 2 · active not recruiting Phase II Trial of Neoadjuvant Chemotherapy (NAC) Alone or in Combination With Immunotherapy Vaccine PRGN-2009 in Subjects With Newly Diagnosed HPV-Associated Oropharyngeal (Head and Neck) Cancer · condition mapped PROBABILISTIC · 1,344 trials mapped (507 active) | — | — | Oropharyngeal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07636499Phase 1 · active not recruiting Selective Neck Dissection Under Multimodal Assessment for N3 Nasopharyngeal Carcinoma After Radiotherapy · condition mapped ALIAS · 1,344 trials mapped (507 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00162708Phase 2/Phase 3 · completed Very Intense Radiotherapy-chemotherapy Regimen in Advanced HNSCC · condition mapped ALIAS · 1,344 trials mapped (507 active) | — | — | Malignant Oropharyngeal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00336063Phase 1 · active not recruiting Vorinostat and Azacitidine in Treating Patients With Locally Recurrent or Metastatic Nasopharyngeal Cancer or Nasal Natural Killer T-Cell Lymphoma · condition mapped CURATED_BROADER · 1,344 trials mapped (507 active) | — | — | Nasopharyngeal Keratinizing Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04432597Phase 1/Phase 2 · completed HPV Vaccine PRGN-2009 Alone or in Combination With Anti-PDL1/TGF-Beta Trap (M7824) in Subjects With HPV Associated Cancers · condition mapped CURATED_EXACT · 1,344 trials mapped (507 active) | — | — | Malignant Oropharyngeal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06532279Phase 2 · recruiting Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer · condition mapped ONTOLOGY_EXACT · 1,344 trials mapped (507 active) | — | — | Hypopharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07441681Phase 3 · recruiting Comparing Radiation Plus Cetuximab to Radiation Plus Chemotherapy in People With Head and Neck Cancer Who Cannot Receive Cisplatin · condition mapped CURATED_BROADER · 1,344 trials mapped (507 active) | — | — | Hypopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04920344Phase 2 · active not recruiting Swallowing Outcomes and Circulating Tumor DNA in Patients With HPV Related Oropharyngeal Cancer Treated With Transoral Surgery and Reduced Intensity Adjuvant Therapy · condition mapped ALIAS · 1,344 trials mapped (507 active) | — | — | Human Papillomavirus-Related Oropharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07418034Phase 2 · not yet recruiting A Single Arm Phase II Trial in p16-positive Oropharynx Cancer of Selective Dose De-escalation of nodAl VolumEs at Minimal Risk and Primary Site Disease (SAVED) · condition mapped ONTOLOGY_EXACT · 1,344 trials mapped (507 active) | — | — | Oropharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07764887NA · not yet recruiting Impacted Tooth Management and Osteoradionecrosis Risk in NPC · condition mapped ONTOLOGY_EXACT · 1,344 trials mapped (507 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06712888Phase 3 · active not recruiting Toripalimab vs. Placebo Wtih GP Induction Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma · condition mapped ONTOLOGY_EXACT · 1,344 trials mapped (507 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07762976Phase 2 · recruiting Dynamic Risk-adapted EBV-DNA and MRI-guided De-concurrent Chemotherapy in Nasopharyngeal Carcinoma · condition mapped ONTOLOGY_EXACT · 1,344 trials mapped (507 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04609280Phase 2 · active not recruiting Selective Avoidance of Nodal VolumEs at Minimal Risk (GCC 20110) · condition mapped ALIAS · 1,344 trials mapped (507 active) | — | — | Malignant Oropharyngeal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05979961Phase 3 · active not recruiting Phase III Trial of Concurrent Chemotherapy Alone in Patients With Low-risk Nasopharyngeal Carcinoma · condition mapped ONTOLOGY_EXACT · 1,344 trials mapped (507 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05119036NA · completed Adjuvant Treatment Deintensification After Transoral Surgery for Human Papillomavirus-Positive Squamous Cell Carcinoma · condition mapped ALIAS · 1,344 trials mapped (507 active) | — | — | Oropharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06915038NA · recruiting ctHPVDNA in HPV Positive Squamous Cell Carcinoma of the Oropharynx · condition mapped ALIAS · 1,344 trials mapped (507 active) | — | — | Oropharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07650266Phase 1 · not yet recruiting A Study of Cemiplimab and Fianlimab in People With Nasopharyngeal Carcinoma · condition mapped ONTOLOGY_EXACT · 1,344 trials mapped (507 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07756190Phase 2 · not yet recruiting Radscopal Radiotherapy Plus Immunotherapy for Chemotherapy-Ineligible Patients With Newly Diagnosed Metastatic Nasopharyngeal Cancer: A Single-Center, Open-Label, Phase II Study · condition mapped ONTOLOGY_EXACT · 1,344 trials mapped (507 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03416153Phase 2 · completed Individualized Adaptive De-escalated Radiotherapy for HPV-related Oropharynx Cancer · condition mapped ALIAS · 1,344 trials mapped (507 active) | — | — | Malignant Oropharyngeal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04502407Phase 2 · active not recruiting Trial of De-Intensified Post-operative Chemoradiation Following Robotic Surgery for HPV-positive Oropharyngeal Cancer · condition mapped ALIAS · 1,344 trials mapped (507 active) | — | — | Human Papillomavirus-Related Oropharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04900623Phase 2 · recruiting Risk-adapted Therapy in HPV+ Oropharyngeal Cancer Using Circulating Tumor (ct)HPV DNA Profile - The ReACT Study · condition mapped ALIAS · 1,344 trials mapped (507 active) | — | — | Human Papillomavirus-Related Oropharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06115772recruiting Prospective Assessment of HPV Associated Anogenital Pathology in Female Patients and Female Partners of Patients With Confirmed HPV Associated Oropharyngeal Carcinoma, PAP-OP Study · condition mapped ALIAS · 1,344 trials mapped (507 active) | — | — | Human Papillomavirus-Related Oropharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06254911Phase 2 · recruiting Pre-operative Atezolizumab in Patients With Resectable, Human Papillomavirus Related Oropharyngeal Carcinoma · condition mapped CURATED_BROADER · 1,344 trials mapped (507 active) | — | — | Malignant Oropharyngeal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06445114Phase 2 · recruiting Using CircuLating Tumor DNA to Risk Adapt Post-Operative Therapy for HPV-associated Oropharyngeal Cancer · condition mapped CURATED_EXACT · 1,344 trials mapped (507 active) | — | — | Malignant Oropharyngeal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05111574Phase 2 · active not recruiting Using Nivolumab Alone or With Cabozantinib to Prevent Mucosal Melanoma Return After Surgery · condition mapped ONTOLOGY_EXACT · 1,344 trials mapped (507 active) | — | — | Nasopharyngeal Mucosal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03803774Phase 1 · active not recruiting Birinapant and Intensity Modulated Re-Irradiation Therapy in Treating Patients With Locally Recurrent Head and Neck Squamous Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 1,344 trials mapped (507 active) | — | — | Nasopharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07741110completed Biomarker Analysis Data From a Randomized Phase II Study in Patients With Nasopharyngeal Carcinoma Treated With Chemotherapy and Radiotherapy · condition mapped ONTOLOGY_EXACT · 1,344 trials mapped (507 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02567422Phase 1 · active not recruiting Testing the Addition of M6620 (VX-970, Berzosertib) to Usual Chemotherapy and Radiation for Head and Neck Cancer · condition mapped CURATED_BROADER · 1,344 trials mapped (507 active) | — | — | Hypopharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05063552Phase 2/Phase 3 · active not recruiting Testing the Use of Investigational Drugs Atezolizumab and/or Bevacizumab With or Without Standard Chemotherapy in the Second-Line Treatment of Advanced-Stage Head and Neck Cancers · condition mapped CURATED_BROADER · 1,344 trials mapped (507 active) | — | — | Hypopharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06947668recruiting Immune Biomarker Study for Cisplatin-ineligible Patients Receiving Chemoradiotherapy With Docetaxel · condition mapped ALIAS · 1,344 trials mapped (507 active) | — | — | Oropharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06457503Phase 4 · recruiting A Study of Toripalimab in Combination With Cisplatin and Gemcitabine in Participants With Recurrent Metastatic Nasopharyngeal Cancer · condition mapped ONTOLOGY_EXACT · 1,344 trials mapped (507 active) | — | — | Nasopharyngeal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07172256Phase 2 · recruiting CUE-101with Pembrolizumab for Locally Advanced HPV+HNSCCs · condition mapped ALIAS · 1,344 trials mapped (507 active) | — | — | Human Papillomavirus-Related Oropharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06854510Phase 2/Phase 3 · active not recruiting Sodium Bicarbonate for Reducing Radiation-Induced Oral Mucositis in Nasopharyngeal Carcinoma. · condition mapped ALIAS · 1,344 trials mapped (507 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04754321Phase 1 · recruiting Combining Immunotherapy Salvage Surgery & IORT Tx Persistent/Recurrent Head & Neck Cancer · condition mapped CURATED_BROADER · 1,344 trials mapped (507 active) | — | — | Pharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06702033Phase 2 · recruiting The Minimalist Trial-2 · condition mapped ONTOLOGY_EXACT · 1,344 trials mapped (507 active) | — | — | Oropharyngeal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06475300Phase 2 · recruiting A Study of BL-B01D1+PD-1 Monoclonal Antibody in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer, Nasopharyngeal Carcinoma and Other Solid Tumors · condition mapped ONTOLOGY_EXACT · 1,344 trials mapped (507 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07528183Phase 2 · recruiting Maintenance Immunotherapy With Deferred Salvage Radiotherapy After Response to Chemoimmunotherapy in Recurrent Nasopharyngeal Carcinoma · condition mapped ALIAS · 1,344 trials mapped (507 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03729518NA · completed TORS De-Intensification Protocol Version 2.0: Dose and Volume Reduction in the Neck · condition mapped CURATED_EXACT · 1,344 trials mapped (507 active) | — | — | Malignant Oropharyngeal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05419089Phase 2 · recruiting The Sinai Robotic Surgery Trial in HPV-related Oropharyngeal Squamous Cell Carcinoma (SIRS 2.0 Trial) · condition mapped ALIAS · 1,344 trials mapped (507 active) | — | — | Human Papillomavirus-Related Oropharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07718620NA · recruiting HPV-associated Oropharyngeal Carcinoma (HPV-OPC) · condition mapped ONTOLOGY_EXACT · 1,344 trials mapped (507 active) | — | — | Oropharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05388773Phase 2 · recruiting Transoral Surgical Resection Followed by De-escalated Adjuvant IMRT in Resectable p16+ Locally Advanced Oropharynx Cancer · condition mapped ALIAS · 1,344 trials mapped (507 active) | — | — | Malignant Oropharyngeal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07241273NA · not yet recruiting SPECT-CT Guided ELEctive Contralateral Neck Treatment in Lateralized Oropharyngeal Cancer · condition mapped ONTOLOGY_EXACT · 1,344 trials mapped (507 active) | — | — | Oropharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04852328Phase 2 · recruiting Three Schedules of CUE-101 Administered Before Surgery or Definitive Chemoradiation Therapy in HLA-A*0201 Positive Patients With Locally Advanced, HPV16-Positive Oropharyngeal Squamous-Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 1,344 trials mapped (507 active) | — | — | Oropharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04874493active not recruiting Patient Reported Outcome Post Radiation Therapy or Chemoradiotherapy Patient Care in Patients With Oropharyngeal Cancer · condition mapped ONTOLOGY_EXACT · 1,344 trials mapped (507 active) | — | — | Oropharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05075980Phase 2 · active not recruiting Intensity Modulated Proton or X-Ray Therapy After Surgery for Treatment of Head and Neck Cancer, the HEADLIGHT Study · condition mapped ONTOLOGY_EXACT · 1,344 trials mapped (507 active) | — | — | Hypopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05787639Phase 2 · active not recruiting Neoadjuvant Immunoradiotherapy With Evorpacept and Pembrolizumab in HPVOPC (Human Papilloma Virus Oropharynx Cancer) · condition mapped ALIAS · 1,344 trials mapped (507 active) | — | — | Malignant Oropharyngeal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06662058NA · recruiting Remote Audiometry to Monitor for Treatment-Related Hearing Loss in Patients With H&N SCC Receiving Cisplatin and/or Radiation · condition mapped ONTOLOGY_EXACT · 1,344 trials mapped (507 active) | — | — | Hypopharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07064902Phase 2 · not yet recruiting Ivonescimab Combined With Chemoradiotherapy in High-Risk Locoregionally Advanced Nasopharyngeal Carcinoma · condition mapped ONTOLOGY_EXACT · 1,344 trials mapped (507 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07665190Phase 2 · recruiting Neoadjuvant EGFR-ADC Combined With Anti-PD-1 Monoclonal Antibody in Resectable Locally Advanced Hypopharyngeal Squamous Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 1,344 trials mapped (507 active) | — | — | Hypopharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07706985Phase 3 · recruiting Efficacy and Safety of TPC Induction Chemotherapy Combined With Nimotuzumab and Toripalimab "Immune Sandwich" Regimen Versus Full-Course Immunotherapy for Locally Advanced Nasopharyngeal Carcinoma · condition mapped ONTOLOGY_EXACT · 1,344 trials mapped (507 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01365169NA · recruiting Association Between Health Care Provider (HCP)-Assessed ECOG Performance Status (PS) and Overall Survival, and Objectively Measure of Physical Activity (PA) Levels in Advance-cancer Patients" · condition mapped CURATED_BROADER · 1,344 trials mapped (507 active) | — | — | Hypopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05799144Phase 2 · recruiting pBI-11 & TA-HPV (With Pembrolizumab as Treatment for Patients w/Advanced, PD-L1 CPS≥1, hrHPV+ Oropharyngeal Cancer · condition mapped CURATED_BROADER · 1,344 trials mapped (507 active) | — | — | Oropharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07705243Phase 3 · recruiting Efficacy and Safety of Becotatug Vedotin (MRG003) Combined With Anti-PD1 as Maintenance Therapy for Recurrent and Metastatic Nasopharyngeal Carcinoma · condition mapped ALIAS · 1,344 trials mapped (507 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05451004Phase 3 · recruiting SPECT-CT Guided ELEctive Contralateral Neck Treatment for Patients With Lateralized Oropharyngeal Cancer · condition mapped CURATED_EXACT · 1,344 trials mapped (507 active) | — | — | Malignant Oropharyngeal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04858269Phase 2 · active not recruiting First Line Weekly Chemo/Immunotherapy for Metastatic Head/Neck Squamous Cell Carcinoma Patients · condition mapped ALIAS · 1,344 trials mapped (507 active) | — | — | Hypopharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07697287Phase 4 · active not recruiting Oral Mucositis Management in Patients Receiving Radiation for Head and Neck Cancer: An Evaluation of a Barrier Based Treatment · condition mapped CURATED_EXACT · 1,344 trials mapped (507 active) | — | — | Malignant Oropharyngeal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05813626Phase 2 · active not recruiting Neoadjuvant Chemotherapy Plus Toripalimab in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma · condition mapped ONTOLOGY_EXACT · 1,344 trials mapped (507 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07552545NA · not yet recruiting Full-wrap Versus Conventional Suspension for Reducing Soft Palate Injury Rate in Transoral Surgery · condition mapped ALIAS · 1,344 trials mapped (507 active) | — | — | Nasopharyngeal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07692906NA · not yet recruiting Multimodal Evaluation-Guided Surveillance-Intervention With Endoscopic Selective Neck Dissection for Post-Radiotherapy N3 Nasopharyngeal Carcinoma · condition mapped ALIAS · 1,344 trials mapped (507 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06797986Phase 1/Phase 2 · recruiting A Phase I/IIa Clinical Trial to Investigate BVAC-E6E7 in Subjects With HPV Positive HNSCC. · condition mapped ALIAS · 1,344 trials mapped (507 active) | — | — | Human Papillomavirus-Related Oropharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07578467Phase 1/Phase 2 · not yet recruiting Combining Neo-adjuvant ATR-inhibition With Nodal SBRT for Early-stage Resectable HPV+ OPSCCs · condition mapped ALIAS · 1,344 trials mapped (507 active) | — | — | Human Papillomavirus-Related Oropharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07578727NA · not yet recruiting A Multicenter, Prospective, Phase III Clinical Study of Proton Intensity-modulated Radiotherapy Versus Photon Intensity-modulated Radiotherapy for Untreated Non-metastatic Nasopharyngeal Carcinoma · condition mapped ONTOLOGY_EXACT · 1,344 trials mapped (507 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05751486Phase 1 · completed A Clinical Study to Evaluate the Safety and Tolerability of JS001sc in Advanced Nasopharyngeal Carcinoma · condition mapped CURATED_BROADER · 1,344 trials mapped (507 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06788002Phase 2 · recruiting LDRT and Chemoimmunotherapy in NPC With Liver Metastasis · condition mapped ALIAS · 1,344 trials mapped (507 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07686575recruiting Objective Response Rate of Ivonescimab With Chemotherapy in Locally Advanced Resectable Oral and Oropharyngeal Squamous Cell Carcinoma · condition mapped ALIAS · 1,344 trials mapped (507 active) | — | — | Oropharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03952585Phase 2/Phase 3 · active not recruiting De-intensified Radiation Therapy With Chemotherapy (Cisplatin) or Immunotherapy (Nivolumab) in Treating Patients With Early-Stage, HPV-Positive, Non-Smoking Associated Oropharyngeal Cancer · condition mapped ONTOLOGY_EXACT · 1,344 trials mapped (507 active) | — | — | Oropharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05522881recruiting The Registry Study of Genetic Alterations of Oropharyngeal Cancer in Taiwan · condition mapped ONTOLOGY_EXACT · 1,344 trials mapped (507 active) | — | — | Oropharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01772706NA · completed Laser Mucite ORL : Effectiveness of Laser Therapy for Mucositis Induced by a Radio-chemotherapy in Head and Neck Cancer · condition mapped ALIAS · 1,344 trials mapped (507 active) | — | — | Oropharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04287868Phase 1/Phase 2 · completed Combination Immunotherapy in Subjects With Advanced HPV Associated Malignancies · condition mapped CURATED_EXACT · 1,344 trials mapped (507 active) | — | — | Malignant Oropharyngeal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02012699recruiting Integrated Cancer Repository for Cancer Research · condition mapped CURATED_EXACT · 1,344 trials mapped (507 active) | — | — | Malignant Hypopharyngeal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07674706NA · not yet recruiting Evaluating the Optimal Timing of Acupuncture for Managing Chemoradiation-induced Xerostomia in Patients With Head and Neck Cancers · condition mapped ONTOLOGY_EXACT · 1,344 trials mapped (507 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04151082Phase 1/Phase 2 · recruiting High Dose Steroid Therapy (Prednisone or Methylprednisolone) for the Improvement of Symptoms of Late Radiation-Associated Lower Cranial Neuropathy in Oropharyngeal Cancer Survivors · condition mapped ONTOLOGY_EXACT · 1,344 trials mapped (507 active) | — | — | Oropharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04862650Phase 2 · active not recruiting Cemiplimab, Low-Dose Paclitaxel and Carboplatin for the Treatment of Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck · condition mapped CURATED_BROADER · 1,344 trials mapped (507 active) | — | — | Hypopharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05050162Phase 2/Phase 3 · suspended Comparing Cisplatin Every Three Weeks to Cisplatin Weekly When Combined With Radiation for Patients With Advanced Head and Neck Cancer · condition mapped CURATED_BROADER · 1,344 trials mapped (507 active) | — | — | Hypopharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04528394Phase 2 · completed Proton Versus Photon Radiotherapy for Nasopharyngeal Carcinoma · condition mapped ONTOLOGY_EXACT · 1,344 trials mapped (507 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04925544Phase 2 · active not recruiting Novel Small Molecule EBNA1 Inhibitor, VK 2019, in Patients With Epstein Barr Virus (EBV)-Positive Nasopharyngeal Cancer (NPC) and Other Epstein-Barr Virus (EBV)-Associated Cancers, With Pharmacokinetic and Pharmacodynamic Correlative Studies · condition mapped CURATED_EXACT · 1,344 trials mapped (507 active) | — | — | Malignant Nasopharyngeal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05996523Phase 2 · active not recruiting Phase II Trial of Immunotherapeutic HPV Vaccine PRGN-2009 With Pembrolizumab Before Standard Treatment in Subjects With Newly Diagnosed HPV-Associated Oropharyngeal Cancer · condition mapped ONTOLOGY_EXACT · 1,344 trials mapped (507 active) | — | — | Oropharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06592599Phase 2 · recruiting Gemcitabine + Docetaxel + Toripalimab Induction in Epstein-Barr Virus (EBV) Associated Nasopharyngeal Carcinoma(NPC) · condition mapped ONTOLOGY_EXACT · 1,344 trials mapped (507 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03097939Phase 2 · active not recruiting Phase 2 Trial of Ipilimumab and Nivolumab in Nasopharyngeal Carcinoma · condition mapped ONTOLOGY_EXACT · 1,344 trials mapped (507 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04965792active not recruiting Post-treatment Surveillance in HPV+ Oropharyngeal SCC · condition mapped ONTOLOGY_EXACT · 1,344 trials mapped (507 active) | — | — | Oropharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02834013Phase 2 · active not recruiting Nivolumab and Ipilimumab in Treating Patients With Rare Tumors · condition mapped ONTOLOGY_EXACT · 1,344 trials mapped (507 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04533750Phase 1 · active not recruiting Testing the Addition of M3814 (Peposertib) to Radiation Therapy for Patients With Advanced Head and Neck Cancer Who Cannot Take Cisplatin · condition mapped CURATED_BROADER · 1,344 trials mapped (507 active) | — | — | Hypopharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06682442NA · recruiting Induction Chemotherapy Response-Guided Radiation for EBV-Associated Nasopharyngeal Carcinoma · condition mapped ONTOLOGY_EXACT · 1,344 trials mapped (507 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00494182Phase 2 · active not recruiting Sorafenib in Combination With Carboplatin and Paclitaxel in Treating Participants With Metastatic or Recurrent Head and Neck Squamous Cell Cancer · condition mapped CURATED_BROADER · 1,344 trials mapped (507 active) | — | — | Hypopharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04667585NA · active not recruiting Radiotherapy Dose De-escalation in HPV-Associated Cancers of the Oropharynx · condition mapped ALIAS · 1,344 trials mapped (507 active) | — | — | Malignant Oropharyngeal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05639972Phase 1/Phase 2 · recruiting E7 T-cell Receptor (TCR) -T Cell Induction Therapy for Locoregionally Advanced HPV-associated Cancers · condition mapped ALIAS · 1,344 trials mapped (507 active) | — | — | Human Papillomavirus-Related Oropharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05686226Phase 2 · recruiting E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers · condition mapped ALIAS · 1,344 trials mapped (507 active) | — | — | Malignant Oropharyngeal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03224000Phase 2 · active not recruiting Trial of Magnetic Resonance Imaging Guided Radiotherapy Dose Adaptation in Human Papilloma Virus Positive Oropharyngeal Cancer · condition mapped CURATED_EXACT · 1,344 trials mapped (507 active) | — | — | Malignant Oropharyngeal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07303283Phase 2 · not yet recruiting Becotatug Vedotin as Adjuvant Therapy For High-risk Nasopharyngeal Carcinoma · condition mapped ONTOLOGY_EXACT · 1,344 trials mapped (507 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06821243recruiting Patients With Human Papillomavirus-associated Head and Neck Cancer for the Discovery of Predictive Biomarkers to Guide Clinical Intervention · condition mapped ALIAS · 1,344 trials mapped (507 active) | — | — | Oropharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07590024Phase 3 · recruiting RAIRI Model-Guided Adjuvant Therapy in Nasopharyngeal Carcinoma · condition mapped ONTOLOGY_EXACT · 1,344 trials mapped (507 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07628062Phase 2 · not yet recruiting Phase 2 Study of NAI, HPV Vaccine, and Nab-Paclitaxel in HPV-Positive Oropharyngeal Cancer Followed by De-Intensified Radiation Compared With Standard Chemoradiation · condition mapped ALIAS · 1,344 trials mapped (507 active) | — | — | Human Papillomavirus-Related Oropharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07618078recruiting Real-World RAIRI-Guided Risk Stratification for Adjuvant Therapy Benefit After Chemoradiotherapy in NPC · condition mapped ONTOLOGY_EXACT · 1,344 trials mapped (507 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04825990Phase 2 · active not recruiting Pembrolizumab and Olaparib in Recurrent/Metastatic, Platinum Resistant Nasopharyngeal Cancer · condition mapped ONTOLOGY_EXACT · 1,344 trials mapped (507 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05211232Phase 3 · active not recruiting Neoadjuvant and Adjuvant Tislelizumab for Nasopharyngeal Carcinoma · condition mapped ONTOLOGY_EXACT · 1,344 trials mapped (507 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06851663Phase 2/Phase 3 · recruiting Trop2-targeted immunoPET Imaging of Solid Tumors · condition mapped CURATED_EXACT · 1,344 trials mapped (507 active) | — | — | Malignant Nasopharyngeal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05145660Phase 3 · active not recruiting Optimization of Cervical Nodal CTV for Early and Medium Stage NPC · condition mapped ONTOLOGY_EXACT · 1,344 trials mapped (507 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05910827Phase 1/Phase 2 · recruiting A Phase Ib/II Study of an Anti-HER3 Antibody, HMBD-001, With Cetuximab +/- Docetaxel in Advanced Squamous Cell Cancers · condition mapped ALIAS · 1,344 trials mapped (507 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02254278Phase 2 · completed Reduced-Dose Intensity-Modulated Radiation Therapy With or Without Cisplatin in Treating Patients With Advanced Oropharyngeal Cancer · condition mapped CURATED_BROADER · 1,344 trials mapped (507 active) | — | — | Oropharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05198479Phase 2 · suspended Phase II 177Lu-DOTATATE Study in Metastatic NPC With a Safety Run-in · condition mapped CURATED_BROADER · 1,344 trials mapped (507 active) | — | — | Malignant Nasopharyngeal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05800574Phase 2 · recruiting Lymphoscintigraphy Directed Elective Neck Radiation for p16+ Favorable Risk Oropharynx Cancer · condition mapped ALIAS · 1,344 trials mapped (507 active) | — | — | Malignant Oropharyngeal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07325539Phase 2 · recruiting LDRT Combined With Toripalimab and Chemotherapy for Recurrent/Metastatic NPC · condition mapped ALIAS · 1,344 trials mapped (507 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06234748Phase 2 · active not recruiting Trial of Individualized Adaptive RT in HPV-related High Risk Oropharynx Cancer · condition mapped ALIAS · 1,344 trials mapped (507 active) | — | — | Malignant Oropharyngeal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07497607Phase 2 · recruiting Reduced Elective Nodal and CTV Dose for HPV+ Oropharyngeal Squamous Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 1,344 trials mapped (507 active) | — | — | Oropharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01552434Phase 1 · terminated Bevacizumab and Temsirolimus Alone or in Combination With Valproic Acid or Cetuximab in Treating Patients With Advanced or Metastatic Malignancy or Other Benign Disease · condition mapped CURATED_BROADER · 1,344 trials mapped (507 active) | — | — | Pharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06277050Phase 3 · recruiting Maintenance Therapy With Toripalimab and Capecitabine Versus Capecitabine Alone in High-risk Nasopharyngeal Carcinoma · condition mapped ONTOLOGY_EXACT · 1,344 trials mapped (507 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07584499Phase 1 · recruiting Phase I Study of Becotatug Vedotin for Safety and Efficacy in EGFR-Positive Pediatric Relapsed/Refractory or Metastatic Solid Tumors · condition mapped ONTOLOGY_EXACT · 1,344 trials mapped (507 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05363709Phase 2 · withdrawn BALSTILIMAB on Viral Clearance in HPV+ Oropharyngeal Cancer Patients · condition mapped CURATED_EXACT · 1,344 trials mapped (507 active) | — | — | Malignant Oropharyngeal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05541016Phase 2 · recruiting De-Escalated Adjuvant and Definitive Radiation Therapy Informed by DART 2.0 ctHPV-DNA · condition mapped ONTOLOGY_EXACT · 1,344 trials mapped (507 active) | — | — | Human Papillomavirus-Related Oropharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06747390Phase 1 · recruiting Intratumoral Lidocaine Injection Before Oropharyngeal Cancer Surgery · condition mapped ONTOLOGY_EXACT · 1,344 trials mapped (507 active) | — | — | Oropharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06852638Phase 2 · recruiting CD70-targeted immunoPET Imaging of Malignant Cancers · condition mapped ONTOLOGY_EXACT · 1,344 trials mapped (507 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07581821Phase 2 · recruiting Sintilimab Combined With Anlotinib and Taxane-Based Chemotherap for Recurrent/Metastatic Nasopharyngeal Carcinoma · condition mapped ONTOLOGY_EXACT · 1,344 trials mapped (507 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03930498Phase 2 · active not recruiting Programmed Death-1 (PD-1) Antibody Combined With Chemoradiotherapy in High-risk Recurrent Nasopharyngeal Carcinoma · condition mapped CURATED_BROADER · 1,344 trials mapped (507 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04436965Phase 3 · recruiting Effect of Standard Nutrition Therapy on Nutritional Status and Prognosis in Locoregionally Advanced Nasopharyngeal Carcinoma Patients With Malnutrition · condition mapped ONTOLOGY_EXACT · 1,344 trials mapped (507 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05340491Phase 3 · recruiting Chemoradiotherapy Plus Anti-PD1 in Recurrent NPC: A Multicenter, Open-label, Randomised, Controlled, Phase III Trial · condition mapped ONTOLOGY_EXACT · 1,344 trials mapped (507 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05780372Phase 3 · active not recruiting Reduced Volume of Neck Prophylactic Irradiation in Nasopharyngeal Carcinoma · condition mapped ONTOLOGY_EXACT · 1,344 trials mapped (507 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05941741Phase 3 · recruiting IC Plus Low-dose Radiation Plus Cadonilimab in LANPC · condition mapped ONTOLOGY_EXACT · 1,344 trials mapped (507 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06197776recruiting Investigation of Multi-omics Technique to Predict the Efficacy of Chemoradiotherapy Combined With Immunotherapy for r/m NPC · condition mapped ONTOLOGY_EXACT · 1,344 trials mapped (507 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06323239Phase 2 · recruiting SBRT and LDRT Combined With PD-1 Antibody and Chemotherapy in r/m Nasopharyngeal Carcinoma · condition mapped ONTOLOGY_EXACT · 1,344 trials mapped (507 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06802835Phase 1/Phase 2 · recruiting EGFR Antibody Combined With PD-1 Inhibitor and Chemotherapy in R/M Nasopharyngeal Carcinoma · condition mapped ALIAS · 1,344 trials mapped (507 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06984861Phase 2 · recruiting A Study of Reduced Radiation Therapy With Chemotherapy in People With HPV-Positive Throat Cancer · condition mapped ONTOLOGY_EXACT · 1,344 trials mapped (507 active) | — | — | Oropharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06997068Phase 2 · recruiting Methotrexate, Erlotinib, and Celecoxib for the Treatment of Recurrent/Metastatic Head and Neck Cancer in a Rural Midwest United States Population · condition mapped ALIAS · 1,344 trials mapped (507 active) | — | — | Malignant Hypopharyngeal Neoplasm | 1 | Observed | clinicaltrials | graph → |